CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


COVID 19 Diagnostic TestWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug687 Cross-sectional study examining the impact of information sources to obtain information about COVID-19 on depression and anxiety symptoms Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D001008 Anxiety Disorders NIH 0.17

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic: A Descriptive Study of Patients With SARS-CoV-2 RT-PCR Performed

Hong Kong public healthcare system is facing tremendous pressure under the COVID-19 pandemic. As the virus spread in Hong Kong, Hong Kong Sanatorium & Hospital (HKSH) is one of the first private hospitals which immediately provide reliable and rapid COVID-19 test -- Reverse Transcription Polymerase Chain Reaction (RT-PCR). Early provision of the RT-PCR screening test for COVID-19 not only facilitates identification of COVID-19 but also contains the spread of the virus in the community and frontline medical staff. Since description of role of private hospital in Hong Kong amid COVID-19 pandemic is lacking, this study will describe COVID-19 screening algorithm and methodology. A retrospective analysis on clinical characteristics, laboratory findings as well as outcome of patients who underwent COVID-19 test in HKSH is also performed.

NCT04416061 COVID Diagnostic Test: COVID 19 Diagnostic Test

Primary Outcomes

Description: Proportion of asymptomatic subjects (%) who underwent COVID 19 test

Measure: Proportion of asymptomatic subjects

Time: 1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong

Secondary Outcomes

Description: Proportion of subjects (%) with recent contact history

Measure: Proportion of subjects with recent contact history

Time: 1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong

Description: Proportion of subjects (%) with recent travel history

Measure: Proportion of subjects with recent travel history

Time: 1 Feb 2020 until the 14th consecutive day without any local infection in Hong Kong


No related HPO nodes (Using clinical trials)